Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Intramuscular ketamine vs. midazolam for rapid risk-reduction in suicidal, depressed emergency patients: Clinical trial design and rationale

Journal of Affective Disorders Reports(2023)10.1016/j.jadr.2023.100690Source: DataRank Database

Intramuscular ketamine vs. midazolam for rapid risk-reduction in suicidal, depressed emergency patients: Clinical trial design and rationale is a research paper published in Journal of Affective Disorders Reports (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.38)OA: goldTopics (26)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Ryan E. Lawrence ORCID,Hanga Galfalvy ORCID,John G. Keilp ORCID,Vivek K. Moitra,J. John Mann ORCID

Live enrichment

PubMed:38283689 PMC:PMC10812090 OpenAlex:https://openalex.org/W4389280566

National Institutes of Health

Grant: R01 MH125155

National Institutes of Health

Grant: 1R01MH125155-01

IM Ketamine for rapid reduction of suicidal thoughts in high-risk emergency room patients: a midazolam-controlled trial

National Institute of Mental Health

FWCI

0.38

Citation Percentile

0.6%

Citation Trend

2024

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.jadr.2023.100690

publisherhttps://doi.org/10.1016/j.jadr.2023.100690

publisherhttps://api.elsevier.com/content/article/PII:S2666915323002275?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666915323002275?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38283689

Fields of Study

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesElectroconvulsive Therapy Studies03 medical and health sciences0302 clinical medicine

Keywords

Suicidal ideationMedicineRandomized controlled trialKetamineEmergency departmentDepression (economics)PsychiatryClinical trialMidazolamSuicide attemptEmergency medicinePoison controlSuicide preventionAnesthesiaInternal medicineSuicideClinical Trial DesignIntramuscularRZ400-408Mental healingArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Intramuscular ketamine vs. midazolam for rapid risk-reduction in suicidal, depressed emergency patients: Clinical trial design and rationale

FAIR Checklist

Authors (7)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)